Gruenenthal Gmbh

Lg Electronics Inc.

Other

Medifron Dbt Inc.

Grunenthal Gmbh

Jmackem Co., Ltd

Jeewoo Lee

Thomas Christoph

Gregor Bahrenberg

Robert Frank

Klaus Schiene

Derek John Saunders

Jean De Vry

Bernhard Lesch

Nils Damann

Sven Frormann

Bernd Sundermann

Hannelore Stockhausen

Myeong-Seop Kim

Yong-Soo Kim

Mansoo Sin

Byoungyong Hong

Kyungsoon Park

Robert Frank-Foltyn

Young-Ho Park

Michael Przewosny

Young-Ger Suh

Hee-Doo Kim

Hyeung-Geun Park

Uhtaek Oh

Christopher Habermann

Hyung Chul Ryu

Jihyae Ann

Myeon-Seop Kim

The invention relates to oxazole and thiazole-based carboxamide and urea derivatives as vanilloid receptor ligands, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.

Substituted oxazole- and thiazole-based carboxamide and urea derivatives as vanilloid receptor ligands II

Substituted phenylureas and phenylamides, processes for their preparation, pharmaceutical compositions containing these compounds, and the use of these compounds for preparing pharmaceutical compositions.

Substituted phenylureas and phenylamides as vanilloid receptor ligands

A mobile terminal capable of being charged in a wired or wireless manner is disclosed. Some embodiments of the disclosed mobile terminal include a terminal body having a battery, a contact unit formed at one side of the terminal body and coupled to an adaptor, and a plurality of conductive lines configured to connect the contact unit with the battery, where a first conductive line passes through a first charging unit configured to charge the battery with power received wirelessly from a wireless power transmitter, where a second conductive line passes through the second charging unit, and the first conductive line and the second conductive line diverge at a first point and converge at a second point between the contact unit and the battery.

Mobile terminal capable of being charged in a wired or wireless manner

A wireless power transmitter includes a body having a coil module therein, and configured to transmit power in a wireless manner, a blowing module configured to cool the coil module by moving a fluid by convection and a guide module extending from the blowing module to outside of the body such that the fluid from the blowing module is discharged to outside of the body after cooling the coil module. The coil module has a shape corresponding to an outer circumference of the coil module partially or wholly.

Wireless power transmitter

The invention relates to substituted phenylureas and phenylamides, to processes for the preparation thereof, to pharmaceutical compositions containing these compounds and also to the use of these compounds for preparing pharmaceutical compositions.

Substituted bicyclic aromatic carboxamide and urea compounds as vanilloid receptor ligands, pharmaceutical compositions containing these compounds, and a method of using these compounds in the treatment and/or inhibition of pain and further diseases and/or disorders mediated at least in part via the vanilloid receptor 1 (VR1/TRPV1).

Substituted bicyclic aromatic carboxamide and urea compounds as vanilloid receptor ligands

The invention relates to aryl or N-heteroaryl substituted methanesulfonamide derivatives as vanilloid receptor ligands, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.

Aryl or N-heteroaryl substituted methanesulfonamide derivatives as vanilloid receptor ligands

Vanilloid receptor ligand compounds corresponding to formula I: a process for producing such compounds, pharmaceutical compositions containing them, and the use of such compounds to treat pain and various other vanilloid receptor mediated conditions.

Vanilloid receptor ligands, pharmaceutical compositions containing them, process for making them, and use thereof for treating pain and other conditions

Vanilloid receptor ligand compounds corresponding to formula I: pharmaceutical compositions containing such compounds, a process for producing such compounds, and methods of using such compounds for treating or inhibiting pain and various other disorders or conditions.

Vanilloid receptor ligands, pharmaceutical compositions containing them, process for making them, and use thereof to treat pain and other conditions

The invention relates to amine substituted methanesulfonamide derivatives as vanilloid receptor ligands, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.

Amine substituted methanesulfonamide derivatives as vanilloid receptor ligands

Compounds corresponding to formula I: which act as vanilloid receptor ligands, pharmaceutical compositions containing such compounds, a process for the producing such compounds, and the use thereof to treat or inhibit pain and/or various other disorders or conditions.

Vanilloid receptor ligands, pharmaceutical compositions containing them, process for making them and use thereof for treating pain and other conditions

The present invention relates to novel vanilloid receptor ligands, to a process for the production thereof, to pharmaceutical preparations containing these compounds and to the use of these compounds for the production of pharmaceutical preparations.

Vanilloid receptor ligands and use thereof for the production of pharmaceutical preparations

Compounds corresponding to formula I: which act as vanilloid receptor ligands, pharmaceutical compositions containing such compounds, a method for producing the compounds, and the use of such compounds to treat pain and various other conditions.

Vanilloid receptor ligand compounds, pharmaceutical compositions containing them, a method of producing them and the use thereof to treat pain and various other conditions

Growing community of inventors

Seoul, South Korea

Jeewoo Lee